Harrington Discovery Institute at University Hospitals logo

Harrington Discovery Institute at University Hospitals

North America, Ohio, United States, Cleveland

Description

Harrington Discovery Institute at University Hospitals aims to advance medicine and society.

Investor Profile

Harrington Discovery Institute at University Hospitals has made 5 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (60%)
  • Series A (40%)

Country Focus

  • United Kingdom (60%)
  • United States (40%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Harrington Discovery Institute at University Hospitals frequently co-invest with?

Elm Street Ventures
North America, Connecticut, United States, New Haven
Co-Investments: 1
Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 2
Spring Mountain Capital
North America, New York, United States, New York
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 3
Novateur Ventures
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
Life Science Angels
North America, California, United States, Sunnyvale
Co-Investments: 1
Cambridge Innovation Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2

Which angels does Harrington Discovery Institute at University Hospitals often collaborate with?

BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Harrington Discovery Institute at University Hospitals?

Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedOct 24, 2024
Amount Raised: $31,000,000
AlveoGene

Oxford, Oxfordshire, United Kingdom

AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy.

BiotechnologyHealth CareTherapeutics
SeedSep 14, 2023
PIC Therapeutics

Natick, Massachusetts, United States

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series AOct 19, 2022
Amount Raised: $35,000,000
Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedApr 25, 2022
Amount Raised: $13,119,114
Allyx Therapeutics

New Haven, Connecticut, United States

Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.

BiotechnologyHealth CareLife ScienceMedical
Series AJun 1, 2021
Amount Raised: $7,581,493